Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of Structural Features of Peptides on Their Affinity to Cotton Linters Paper.

ACS omega·2026
Same author

Endothelial ZBTB16: a molecular shield against cardiac aging.

European heart journal·2026
Same author

A Rare Case Report of a Human <i>Dirofilaria repens</i> Infection.

Microorganisms·2025
Same author

Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart.

Cardiovascular research·2025
Same author

Precision oncology - Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Investigating Cellulose Binding of Peptides Derived from Carbohydrate Binding Module 1.

Biomacromolecules·2024

Related Experiment Video

Updated: Jun 6, 2026

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells
07:09

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells

Published on: July 31, 2012

Expression of recombinant human interleukin-8 and its purification using a single buffer system.

Dana Wiese1, Katja Schmitz

  • 1Karlsruhe Institute of Technology, Institute of Organic Chemistry, Fritz-Haber-Weg 6, D-76131 Karlsruhe, Germany. dana.wiese@ifg.fzk.de

Journal of Immunological Methods
|November 25, 2010
PubMed
Summary

Researchers developed a rapid and efficient method to purify interleukin-8 (IL-8), a key chemokine in inflammation and allergies. This streamlined process yields high-quality IL-8 for use in binding and activity assays, aiding further research into immune responses.

More Related Videos

Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
11:42

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension

Published on: December 28, 2015

Related Experiment Videos

Last Updated: Jun 6, 2026

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells
07:09

A Convenient and General Expression Platform for the Production of Secreted Proteins from Human Cells

Published on: July 31, 2012

Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension
11:42

High Yield Expression of Recombinant Human Proteins with the Transient Transfection of HEK293 Cells in Suspension

Published on: December 28, 2015

Area of Science:

  • Immunology
  • Protein Biochemistry
  • Molecular Biology

Background:

  • Chemokines, such as interleukin-8 (IL-8), are crucial for immune cell trafficking and are implicated in inflammatory and allergic diseases.
  • Studying chemokine interactions with receptors or inhibitors necessitates large quantities of purified chemokine.
  • Existing purification methods can be time-consuming and complex, requiring multiple steps and buffer exchanges.

Purpose of the Study:

  • To develop a fast, efficient, and cost-effective strategy for purifying human interleukin-8 (IL-8, CXCL8).
  • To obtain high-purity IL-8 suitable for downstream applications like binding and activity assays.
  • To minimize endotoxin levels in the final purified protein product.

Main Methods:

  • Expression of IL-8 with a pelB-leader peptide in bacteria, which is subsequently cleaved to yield wild-type IL-8.
  • Recovery of IL-8 from the soluble fraction after cell lysis.
  • Purification using cation exchange chromatography and heparin affinity chromatography with a single buffer system.
  • Inclusion of 0.5% Triton X-114 in the lysis buffer to reduce endotoxin contamination.

Main Results:

  • A high yield of soluble wild-type 72aa IL-8 was obtained.
  • The purification strategy employed cation exchange and heparin affinity chromatography, eliminating the need for dialysis or membrane filtration.
  • The resulting IL-8 protein exhibited low endotoxin levels and was ready for use in functional assays.

Conclusions:

  • The presented strategy offers a rapid, efficient, and cost-effective method for purifying human IL-8.
  • This optimized protocol simplifies the purification process, making high-quality IL-8 readily accessible for immunological research.
  • The low endotoxin levels and ready-to-use nature of the purified IL-8 facilitate its application in various binding and activity assays.